You've been diagnosed with a brain tumor, and when you asked why this happened, you likely heard some version of "we don't really know" or "it's just bad luck." That answer feels inadequate because it is. You didn't come here looking for vague reassurance. You came here because you want to know what the actual research shows about what causes brain tumors.

I've spent weeks going through the epidemiological studies, the toxicology reports, the internal corporate documents that surfaced in litigation, and the genetic research. What I found is that there are documented causes of brain tumors—some involve corporate products where companies had data they didn't share with the public, some involve environmental and occupational exposures, and some involve factors that have nothing to do with anyone's negligence. You deserve to know all of them.

This article walks through every documented cause of brain tumors that has meaningful evidence behind it. Some of these causes have active litigation. Some have none and never will. I'm going to give you the complete picture because that's what you came here for.

The Research-Based Causes of Brain Tumors

Brain tumors don't all have the same cause, and not everyone with a brain tumor will find a clear explanation for why it developed. But the scientific literature has identified multiple factors that increase risk, some dramatically. These range from ionizing radiation with decades of clear evidence, to chemical exposures that emerged in occupational health studies, to genetic conditions that run in families, to products you may have used daily. Here's what the evidence actually shows.

Ionizing Radiation

Ionizing radiation is the most clearly established environmental cause of brain tumors. The mechanism is direct: high-energy radiation damages DNA in brain cells, and when those cells fail to repair the damage correctly or die off as they should, they can become cancerous. This isn't theoretical—it's been documented in multiple populations over decades.

The evidence comes primarily from atomic bomb survivors in Japan, tracked since 1945 in the Life Span Study. A 2012 analysis published in Radiation Research found that survivors exposed to radiation doses above 100 millisieverts had significantly elevated rates of meningiomas and gliomas, the two most common types of brain tumors. The risk increased proportionally with dose. Children exposed during the bombings showed the highest lifetime risk.

Medical radiation to the head also carries documented risk. Children who received radiation therapy for prior cancers, or even children who received radiation treatment for ringworm of the scalp (a common practice in the 1950s), developed brain tumors at elevated rates years later. A 1988 study in the New England Journal of Medicine tracked over 10,000 Israeli children treated with scalp radiation and found they had a relative risk of brain tumors 8.4 times higher than unexposed children.

This is not a corporate cause in most cases—it's a consequence of life-saving medical treatment or catastrophic military events. But it is a documented biological cause with a clear mechanism and strong evidence.

Cell Phone Radiation (Radiofrequency Energy)

The question of whether cell phones cause brain tumors has been contentious for two decades, and the answer is more complicated than either side usually admits. Cell phones emit radiofrequency electromagnetic fields, a form of non-ionizing radiation. The proposed mechanism is that chronic exposure may cause heating of tissue or disruption of cellular processes, potentially leading to tumor development over many years.

The largest study is the INTERPHONE study, coordinated by the International Agency for Research on Cancer and published in 2010. It included over 5,000 brain tumor cases from 13 countries. The overall findings showed no increased risk for most users, but a subgroup analysis found that the highest category of users—those reporting 1,640 or more hours of lifetime use—had an odds ratio of 1.40 for glioma. The authors noted concerns about recall bias.

What makes this a corporate story is not the science alone—it's what the companies knew and when. Internal documents from Motorola and other manufacturers, disclosed in litigation, show that as early as 1994, companies were conducting research on biological effects of radiofrequency radiation. A 1994 Motorola internal memo discussed unpublished studies showing DNA damage in lab settings. These studies were not made public. Industry-funded research has consistently found no effect, while independent research has been more mixed.

In 2011, the World Health Organization's IARC classified radiofrequency electromagnetic fields as "possibly carcinogenic to humans" (Group 2B), the same category as lead and chloroform. The National Toxicology Program released results in 2018 from a $30 million study showing "clear evidence" of malignant schwannomas (a type of tumor) in the hearts of male rats exposed to cell phone radiation, and "some evidence" of gliomas in the brain. Critics noted that rats were exposed at levels higher than typical human use.

There are now thousands of lawsuits filed against cell phone manufacturers alleging that long-term use caused brain tumors. Whether plaintiffs will prevail remains uncertain—the science is still debated. But the pattern of companies minimizing risk while conducting private research is established.

Vinyl Chloride

Vinyl chloride is a chemical used to make PVC plastic. Workers in polyvinyl chloride manufacturing plants have faced decades of exposure, and the health consequences have been extensively documented. The mechanism is metabolic: when vinyl chloride enters the body, it is converted by liver enzymes into reactive metabolites that bind to DNA, causing mutations. Brain tissue is particularly vulnerable.

A 1974 study published in the Journal of Occupational Medicine first linked vinyl chloride exposure to angiosarcoma of the liver in chemical plant workers, but subsequent research identified brain tumors as well. A 2013 meta-analysis in Occupational and Environmental Medicine reviewed 30 years of studies and found a statistically significant association between occupational vinyl chloride exposure and brain cancer, with a relative risk of 1.36.

Internal documents from chemical manufacturers show they knew about cancer risks earlier than they disclosed. B.F. Goodrich, a major PVC producer, conducted animal studies in the 1960s showing liver tumors in rats exposed to vinyl chloride. These findings were shared within the industry but not with workers or regulators until the 1970s, after public reports of worker deaths forced disclosure. The Occupational Safety and Health Administration didn't set enforceable exposure limits until 1974.

If you worked in PVC manufacturing, pipe production, or plastics fabrication between the 1950s and 1980s, your workplace exposure to vinyl chloride may be relevant to your diagnosis. This is a documented occupational cause with established litigation history.

Pesticides (Organophosphates and Carbamates)

Agricultural pesticides, particularly organophosphates and carbamates, have been studied for decades as potential brain tumor risk factors. These chemicals are neurotoxic by design—they kill insects by disrupting nervous system function. The concern is that chronic exposure in humans may damage the DNA of glial cells or neurons, leading to tumor formation.

A 2005 study in Occupational and Environmental Medicine tracked over 55,000 pesticide applicators in the Agricultural Health Study and found elevated rates of glioma among those with the highest cumulative exposure to organophosphate insecticides. Another analysis published in 2020 in the International Journal of Cancer found that farmers with high use of the insecticide lindane had a relative risk of glioma 1.75 times higher than unexposed individuals.

The litigation history here involves companies like Dow Chemical and Syngenta, manufacturers of widely used pesticides like chlorpyrifos. Internal documents in lawsuits have shown that companies were aware of neurotoxic effects in animal studies but continued marketing products for residential and agricultural use. The EPA banned residential use of chlorpyrifos in 2000 but allowed agricultural use until 2021, despite mounting evidence of harm.

If you worked in agriculture, landscaping, pest control, or golf course maintenance, your occupational pesticide exposure is worth documenting with your physician.

Formaldehyde

Formaldehyde is a chemical used in building materials, embalming, textiles, and manufacturing. It's also a known carcinogen. The International Agency for Research on Cancer classified it as a human carcinogen in 2004 based on clear evidence of nasopharyngeal cancer, and listed brain cancer as an additional site of concern.

A 2009 study published in the Journal of the National Cancer Institute followed over 25,000 industrial workers exposed to formaldehyde and found elevated mortality from brain cancer, particularly glioblastoma, with a dose-response relationship. Workers with peak exposure levels above 4 parts per million had significantly higher rates than unexposed workers.

The corporate story involves industries that used formaldehyde extensively—funeral homes, textile mills, particle board manufacturers—and knew about carcinogenic risks before workers did. Internal memos from formaldehyde producers in the 1980s, disclosed in litigation, showed awareness of animal cancer studies while public messaging focused on safe handling rather than carcinogenic potential.

If you worked as a mortician, pathology technician, or in manufacturing environments with formaldehyde exposure, this is a relevant occupational factor.

Genetic Syndromes

Some people develop brain tumors because they inherited a genetic mutation that dramatically increases risk. This isn't a lawsuit, and it isn't anyone's fault—it's biology. But it's a documented cause that explains a subset of cases, and if this applies to you, it has implications for your family.

Neurofibromatosis type 1 (NF1) is caused by mutations in the NF1 gene and affects about 1 in 3,000 people. Individuals with NF1 have a 15-20% lifetime risk of developing optic gliomas and other brain tumors. Neurofibromatosis type 2 (NF2) causes bilateral vestibular schwannomas (acoustic neuromas) in nearly all affected individuals.

Li-Fraumeni syndrome, caused by TP53 gene mutations, confers a 50% lifetime risk of developing cancer, including gliomas and medulloblastomas. Turcot syndrome, associated with mutations in DNA mismatch repair genes, leads to colorectal polyps and brain tumors, particularly glioblastomas.

A 2016 study in JAMA Oncology analyzed tumor samples from over 1,100 brain tumor patients and found that approximately 8% carried inherited mutations in known cancer predisposition genes. Most had no family history and didn't know they were carriers until their tumor was diagnosed.

If you have a family history of brain tumors, early-onset cancers, or multiple primary cancers, genetic counseling and testing may provide answers. This won't change your current diagnosis, but it may inform surveillance for family members.

Prior Cancer Treatment (Chemotherapy)

Some chemotherapy drugs used to treat childhood cancers increase the risk of secondary brain tumors years or decades later. The mechanism involves DNA damage—chemotherapy works by damaging the DNA of rapidly dividing cancer cells, but it can also damage the DNA of healthy cells, including those in the brain.

A 2014 study in the Journal of Clinical Oncology tracked over 14,000 childhood cancer survivors and found that those treated with certain alkylating agents (like lomustine and carmustine) had a fivefold increased risk of developing gliomas as adults. The risk was highest among those treated at younger ages.

This is not a corporate harm—it's an unfortunate consequence of life-saving treatment. Oncologists weigh these risks carefully, and in most cases, the benefit of treating the primary cancer far outweighs the risk of a secondary malignancy. But if you were treated for childhood leukemia, lymphoma, or another cancer, your prior chemotherapy is a relevant factor in understanding why you now have a brain tumor.

Electromagnetic Fields from Power Lines

High-voltage power lines emit extremely low frequency (ELF) electromagnetic fields, and the question of whether living near them increases brain tumor risk has been studied since the 1970s. The proposed mechanism has never been clearly established, but theories involve disruption of cellular signaling or melatonin suppression.

The evidence is inconsistent. A 2000 pooled analysis published in the British Journal of Cancer examined data from nine studies and found no association between residential ELF-EMF exposure and adult brain tumors. However, a 2010 study in the American Journal of Epidemiology found a modest association between childhood exposure and adult glioma, with a relative risk of 1.5 for the highest exposure category.

There is no active litigation for power line EMF exposure and brain tumors in adults, largely because the epidemiological evidence hasn't been strong or consistent enough to meet legal standards. But if you lived near high-voltage transmission lines for extended periods, particularly during childhood, it's part of your exposure history.

No Clear Cause: Sporadic Cases

For many people with brain tumors—likely the majority—there is no identifiable cause. The tumor developed due to a random mutation during cell division, a copying error in DNA that wasn't caught by the body's repair mechanisms. This is sometimes called a "sporadic" case.

It's important to say this clearly: not every injury has a villain. Not every diagnosis has a clear external cause. Cancer is, at its core, a disease of DNA replication, and DNA replication occasionally goes wrong even in the absence of any carcinogen or corporate product. That doesn't make your diagnosis any less devastating, and it doesn't mean you did something wrong or failed to protect yourself.

But if you had significant exposure to any of the documented risk factors above, that exposure is worth investigating. Many people assume their tumor is random when, in fact, they had a decades-long occupational or environmental exposure they didn't realize was relevant.

The Pattern You Should Know About

If you read through the corporate causes above—vinyl chloride, pesticides, formaldehyde, cell phones—you'll notice a recurring pattern. In every case, companies had internal research showing potential harm years or decades before the public knew. In every case, that research was kept internal, shared within the industry, and not disclosed to workers, consumers, or regulators until external pressure or litigation forced it into the open.

This isn't speculation. It's documented in internal memos, meeting minutes, and research reports that surfaced during discovery in lawsuits. B.F. Goodrich knew vinyl chloride caused tumors in animals in the 1960s but didn't disclose it until 1974. Motorola conducted studies on radiofrequency radiation and DNA damage in the 1990s and didn't publish them. Pesticide manufacturers had neurotoxicity data and continued marketing products for residential use.

The timeline is strikingly similar across industries. A product is developed and marketed. Internal research identifies a health risk. That research is kept confidential or minimized. Workers or consumers are exposed for years or decades. Independent researchers eventually identify a health pattern. Litigation forces internal documents into the public record. Regulatory action follows, years late.

This pattern is why we investigate. If a company's product contributed to your brain tumor, there is a significant likelihood that the company knew about the risk before you were ever exposed. That's not bad luck. That's a business decision.

How to Think About Your Own Situation

Now that you understand the documented causes, the next step is to look at your own life and exposure history. This requires going back through your employment records, residential history, and product use over decades. Here's how to approach it systematically.

Start with occupational exposure. Write down every job you've held, particularly those involving chemical exposure, manufacturing, agriculture, laboratory work, or industrial settings. Were you in plastics manufacturing? Did you work with pesticides? Were you a mortician or pathology technician? Did you work in electronics manufacturing or telecommunications? Occupational exposures are often the highest and longest in duration, and they're the most legally relevant.

Next, document residential history. Did you live near industrial facilities, chemical plants, or waste sites? Were there high-voltage power lines near your home during childhood? These exposures are harder to quantify, but they're part of the picture.

Then consider product use. How many years did you use a cell phone, and how heavily? (Check old phone bills or carrier records if you're unsure.) Were you exposed to pesticides in your home, either through treatment services or agricultural drift if you lived in a farming area? Did you work in buildings with significant formaldehyde off-gassing from materials?

Bring this information to your physician. Most doctors don't have time in a standard appointment to take a detailed occupational and environmental history, but if you come with a written timeline, they can include it in your medical record. This documentation becomes important if you later pursue legal action—you need a clear record linking your exposure to your diagnosis.

Ask your doctor whether genetic testing is appropriate. If you have a family history of cancer, early-onset tumors, or if your tumor type is unusual, germline genetic testing can identify inherited mutations. Most insurance covers this when medically indicated.

Finally, gather records. Employment records, safety data sheets from workplaces, residential addresses with dates, phone records showing years of use. These records are much easier to obtain now than they will be five or ten years from now. If you think there's any possibility of a corporate exposure, document it while the trail is still fresh.

If a Corporation Caused This

If you identify a corporate product or chemical exposure that aligns with the documented causes above, you may have a legal claim. Here's what that process actually looks like, without the sales pitch.

First, understand that product liability and toxic tort cases are handled on contingency. You do not pay attorney fees upfront. The law firm advances the costs of investigating your case, obtaining records, hiring medical experts, and filing suit. If the case settles or wins at trial, the firm takes a percentage of the recovery (typically 33-40%) and recoups its costs. If the case is unsuccessful, you owe nothing. This structure exists specifically so that individuals can take on corporations without needing hundreds of thousands of dollars in legal fees.

The process begins with case evaluation. You'll speak with an attorney or case manager, provide your medical records and exposure history, and the firm will investigate whether there's sufficient evidence to proceed. Not every exposure results in a viable case—the law requires proof that the product or chemical more likely than not caused your specific injury, and that the company was negligent or failed to warn of known risks.

If your case is accepted, the firm will file a complaint in civil court. The defendant company will respond, and the case enters discovery—the process of exchanging documents, taking depositions, and building evidence. This is where internal corporate documents come to light. Discovery can take a year or more.

Most cases settle before trial. Companies often prefer to settle rather than risk a jury verdict and the publicity of trial. Settlement amounts vary widely depending on the severity of injury, strength of evidence, and jurisdiction. Some cases go to trial, which can add another year or more to the timeline.

The entire process typically takes two to four years from filing to resolution. That's a long time, especially when you're dealing with a serious diagnosis. But if a corporation's negligence contributed to your brain tumor, the legal system is one of the few mechanisms available to hold them accountable and obtain compensation for medical costs, lost income, and suffering.

You are not required to pursue legal action. Some people want accountability. Others want to focus entirely on treatment and family. Both choices are valid. But if you're considering it, know that the consultation costs you nothing, and you're under no obligation to proceed unless you choose to.

What This Means

If your brain tumor was caused by a chemical you were exposed to at work, a product you used for years, or radiation from an industrial source, that's not bad luck. It's the result of decisions made by people who had data about risks and chose profit over disclosure. Those decisions have names, dates, and documentation.

Not every brain tumor has a corporate cause. Many don't. But enough do that it's worth looking carefully at your own history. The research is clear on which exposures increase risk, and the litigation record is clear on which companies knew about those risks before the public did. You deserve to know both.